Mitsubishi Ufj Trust & Banking Corp Exelixis, Inc. Transaction History
Mitsubishi Ufj Trust & Banking Corp
- $43.4 Billion
- Q3 2024
A detailed history of Mitsubishi Ufj Trust & Banking Corp transactions in Exelixis, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Trust & Banking Corp holds 95,666 shares of EXEL stock, worth $3.45 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
95,666
Previous 71,546
33.71%
Holding current value
$3.45 Million
Previous $1.61 Million
54.45%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EXEL
# of Institutions
504Shares Held
243MCall Options Held
2.54MPut Options Held
2.29M-
Black Rock Inc. New York, NY33.5MShares$1.21 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.3MShares$1.06 Billion0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA25.4MShares$915 Million3.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.4MShares$553 Million0.63% of portfolio
-
State Street Corp Boston, MA11.4MShares$412 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11.6B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...